Literature DB >> 32697282

Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017.

Shayan Cheraghlou1, Hao Feng2, Jeffrey M Cohen1.   

Abstract

Mesh:

Year:  2020        PMID: 32697282      PMCID: PMC7376476          DOI: 10.1001/jamadermatol.2020.2427

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

Review 1.  Management of field change in actinic keratosis.

Authors:  M Vatve; J-P Ortonne; M A Birch-Machin; G Gupta
Journal:  Br J Dermatol       Date:  2007-12       Impact factor: 9.302

2.  Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers.

Authors:  Hao Feng; Jeffrey M Cohen; Andrea L Neimann
Journal:  J Dermatolog Treat       Date:  2018-09-12       Impact factor: 3.359

3.  2013 NCHS Urban-Rural Classification Scheme for Counties.

Authors:  Deborah D Ingram; Sheila J Franco
Journal:  Vital Health Stat 2       Date:  2014-04

4.  Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015.

Authors:  Sally Y Tan; Elizabeth Buzney; Arash Mostaghimi
Journal:  J Am Acad Dermatol       Date:  2018-03-21       Impact factor: 11.527

5.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

6.  Skin cancer is among the most costly of all cancers to treat for the Medicare population.

Authors:  Tamara Salam Housman; Steven R Feldman; Phillip M Williford; Alan B Fleischer; Neal D Goldman; Jose M Acostamadiedo; G John Chen
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.